The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) — Stella

View on ClinicalTrials.gov

Recruiting

Back to Hiv trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Burkina Faso

Centre Muraz/INSP, Bobo-Dioulasso

The Gambia

MRC The Gambia at LSHTM, Fajara

Key details

Sponsor

Institut de Recherche pour le Developpement

Collaborators

Centre Muraz, Medical Research Council

Enrollment target

~2,800 participants

Started

March 2024

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Sex

Female only

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.